To study effect of Trikarshika ghanvati in treating gout ( vaatarakta)

Randomised Controlled Trial of Trikarshika Ghanavati in the management of vaatarakta with special reference to Gout . - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087320

Enrollment

Registered

2025-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having uric acid level between 6mg/dl to 10mg/dl

Exclusion criteria

Exclusion criteria: 1. Amavata (Rheumatoid Arthritis) 2. Sandhigata vaata 3. With H/O malignancy HIV trauma Cardiac disease Neurological disorders etc associated with gout 4. Pregnant women and lactating mother

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of gout.Timepoint: 30 days	—

Secondary

Measure	Time frame
Where trial group stands in comparison with control group in reducing signs and symptoms of goutTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Divya Shriniwas Pogul

Department of Kayachikitsa Shree Saptashrungi Ayurved Mahavidyalaya And Hospital Nashik

drpvjagtap@gmail.com9822852144

Outcome results